“Parlons demain” with Dimitri Labat
Parlons demain is a serie of interviews with Université Paris Cité alumni that enlighten the future.
Dimitri is one of them ! He’s the co-founder of Chipiron. Let’s meet him.
Chipiron has been singled out by Challenges magazine as one of the 100 start-ups to invest in in 2022. Its promise: to make MRI (magnetic resonance imaging) accessible to everyone, everywhere.
Dimitri’s academic background is outstanding. He holds an agrégation in physics, a degree from the Ecole Normale Supérieure and a Phd in condensed matter physics. Dimitry is a true jack-of-all-trades ! He has taught Physics, done fundamental research and worked at the Banque de France where he designed and implemented mathematical models to monitor the activity of insurance companies.
When he created Chipiron, Dimitri wanted to “take research out of the laboratory and make it have a direct impact on people’s lives and on society”. His goal is to democratize MRI and give access to this powerful medical imaging technique to all of those who need it to benefit from the best medical imaging technique available.
À lire aussi
[Paris-NUS] 2026 Calls for Project Results and Awarded Projects
Building on its privileged partnership between Université Paris Cité (UPCité) and the National University of Singapore (NUS), three calls for proposals were launched in 2025, giving both institutions’ communities the opportunity to further strengthen and expand their...
read more
One Health Summit: the Graduate School 1H-EID at the heart of global health issues
As soils harden, roots reveal a previously unknown ability to adapt
As part of an international collaboration, a team from the Matter and Complex Systems laboratory (MSC – Université Paris Cité/CNRS) identifies an ingenious mechanism that allows roots to adapt to rigidifying grounds, which increases because of climate change. These...
read more
Launch of the Graduate School Cardiovascular and Blood Sciences (CVBS): An Integrated Approach to Circulatory Health
The Graduate School Cardiovascular Sciences is expanding its scope by integrating hematology and becoming the Graduate School Cardiovascular & Blood Sciences (CVBS), dedicated to cardiovascular sciences and blood. Through this evolution, Université Paris Cité...
read more